Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement
F Tubach, P Ravaud, G Baron, B Falissard… - Annals of the …, 2005 - ard.bmj.com
Background: In clinical trials, at the group level, results are usually reported as mean and
standard deviation of the change in score, which is not meaningful for most readers …
standard deviation of the change in score, which is not meaningful for most readers …
Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state
F Tubach, P Ravaud, G Baron, B Falissard… - Annals of the …, 2005 - ard.bmj.com
Background: The patient acceptable symptom state (PASS) is the value beyond which
patients can consider themselves well. This concept can help in interpreting results of …
patients can consider themselves well. This concept can help in interpreting results of …
Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain …
F Tubach, P Ravaud, E Martin‐Mola… - Arthritis care & …, 2012 - Wiley Online Library
Objective To estimate the minimum clinically important improvement (MCII) and patient
acceptable symptom state (PASS) values for 4 generic outcomes in 5 rheumatic diseases …
acceptable symptom state (PASS) values for 4 generic outcomes in 5 rheumatic diseases …
The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients
M Dougados, MA d'Agostino, J Benessiano… - Joint bone spine, 2011 - Elsevier
OBJECTIVES: The French Society of Rheumatology has initiated a large national
multicenter, longitudinal, prospective follow-up of patients presenting with early inflammatory …
multicenter, longitudinal, prospective follow-up of patients presenting with early inflammatory …
[PDF][PDF] Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a multicenter, randomized …
M Dougados, D van der Heijde, J Sieper… - Arthritis & …, 2014 - Wiley Online Library
Objective To assess the efficacy of etanercept in the treatment of early active nonsteroidal
antiinflammatory drug (NSAID)–refractory nonradiographic axial spondyloarthritis (SpA) …
antiinflammatory drug (NSAID)–refractory nonradiographic axial spondyloarthritis (SpA) …
The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients
B Combe, J Benessiano, F Berenbaum, A Cantagrel… - Joint bone spine, 2007 - Elsevier
OBJECTIVES: The French Society of Rheumatology initiated a large national multicenter,
longitudinal and prospective cohort, the so-called “ESPOIR cohort study” in order to set up …
longitudinal and prospective cohort, the so-called “ESPOIR cohort study” in order to set up …
Feeling good rather than feeling better matters more to patients
F Tubach, M Dougados, B Falissard… - Arthritis Care & …, 2006 - Wiley Online Library
Objective To determine the most appropriate means to assess the response to treatment in
terms of pain and functional impairment in a chronic rheumatic condition (knee osteoarthritis …
terms of pain and functional impairment in a chronic rheumatic condition (knee osteoarthritis …
A randomised, multicentre, double-blind, placebo-controlled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HEEL trial
Objective Inflammation at the entheses is a distinguishing feature of spondyloarthritis (SpA).
Enthesitis at the heel is the most common location and is often chronic, refractory to standard …
Enthesitis at the heel is the most common location and is often chronic, refractory to standard …
Development of multinational definitions of minimal clinically important improvement and patient acceptable symptomatic state in osteoarthritis
N Bellamy, M Hochberg, F Tubach… - Arthritis care & …, 2015 - Wiley Online Library
Objective The ability to interpret scores from patient‐reported outcome measures at the
individual patient level depends on the availability of valid, clinically meaningful benchmarks …
individual patient level depends on the availability of valid, clinically meaningful benchmarks …
Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study
WP Maksymowych, M Dougados… - Annals of the …, 2016 - ard.bmj.com
Objective To evaluate the efficacy and safety of etanercept (ETN) after 48 weeks in patients
with early active non-radiographic axial spondyloarthritis (nr-axSpA). Methods Patients …
with early active non-radiographic axial spondyloarthritis (nr-axSpA). Methods Patients …